Nexalin Technology (NASDAQ:NXL) Posts Quarterly Earnings Results

Nexalin Technology (NASDAQ:NXL) issued its quarterly earnings data on Friday. The company reported ($0.28) earnings per share for the quarter, Zacks reports. Nexalin Technology had a negative net margin of 3,407.98% and a negative return on equity of 187.59%.

Nexalin Technology Stock Up 10.3 %

Nexalin Technology stock traded up $0.20 during mid-day trading on Friday, reaching $2.15. 115,733 shares of the company’s stock traded hands, compared to its average volume of 1,354,446. Nexalin Technology has a 12-month low of $0.35 and a 12-month high of $4.49. The company has a market cap of $28.60 million, a price-to-earnings ratio of -3.36 and a beta of 4.33. The stock has a 50 day moving average of $2.87 and a two-hundred day moving average of $2.47.

Analysts Set New Price Targets

Separately, Maxim Group restated a “hold” rating on shares of Nexalin Technology in a report on Thursday, December 5th.

Nexalin Technology Company Profile

Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia.